Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China · Delayed Price · Currency is CNY 13.76
-0.13 (-0.94%)
May 20, 2026, 12:34 PM CST
SHE:002275 Revenue
Guilin Sanjin Pharmaceutical had revenue of 525.12M CNY in the quarter ending March 31, 2026, with 12.55% growth. This brings the company's revenue in the last twelve months to 2.10B, down -3.38% year-over-year. In the year 2025, Guilin Sanjin Pharmaceutical had annual revenue of 2.05B, down -6.76%.
Revenue (ttm)
2.10B
Revenue Growth
-3.38%
P/S Ratio
3.88
Revenue / Employee
819.74K
Employees
2,567
Market Cap
8.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.05B | -148.26M | -6.76% |
| Dec 31, 2024 | 2.19B | 22.39M | 1.03% |
| Dec 31, 2023 | 2.17B | 211.87M | 10.81% |
| Jan 1, 2023 | 1.96B | 218.51M | 12.55% |
| Jan 1, 2022 | 1.74B | 174.74M | 11.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition